Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

NCT: NCT05172960 · ACTIVE_NOT_RECRUITING

NCT IDNCT05172960
StatusACTIVE_NOT_RECRUITING
Start Date2022-06-20
Completion2037-01

Brief Summary

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects with symptomatic, severe, calcific aortic stenosis (AS).

Frequently Asked Questions

What is ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve?

ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve is a clinical trial registered under NCT05172960. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05172960?

The current status of NCT05172960 (ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve) is: ACTIVE_NOT_RECRUITING.

When did ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve start?

ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve started on 2022-06-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑